Supplier profile
Astellas Pharma GmbH
Every public-sector award we hold for this supplier, across Germany, from 2 May 2013 to 20 Jan 2026.
Awards won
22
all time
Attributed value
€2
11 shared, unvalued
Buyers
10
public bodies
Active
2013–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| IKK classic | 4 | €2 |
| Techniker Krankenkasse | 4 | not attributable |
| AOK Baden-Württemberg | 3 | not attributable |
| DAK-Gesundheit | 3 | not attributable |
| GWQ ServicePlus AG | 3 | not attributable |
| AOK Bayern – Die Gesundheitskasse | 1 | not attributable |
| AOK Nordost - Die Gesundheitskasse | 1 | not attributable |
| AOK Nordost – Die Gesundheitskasse | 1 | not attributable |
| AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen; Unternehmensbereich Corporate Governance; Geschäftsbereich Zentrale Vergabestelle | 1 | not attributable |
| spectrumK GmbH | 1 | not attributable |
What they win
Awards
All 22 awards we hold
- Germany – Pharmaceutical products – 34. Generikaausschreibung (1er) - Auftragsbekanntmachung ↗GWQ ServicePlus AGshared awardawarded 20 Jan 2026
- Acetylcystein (OTC) ↗GWQ ServicePlus AGshared awardawarded 20 Jan 2026
- Germany – Pharmaceutical products – Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Astellas Pharma GmbH zu Evrenzo(R) ↗IKK classic€1awarded 22 May 2025
- Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Astellas Pharma GmbH zu Evrenzo(R) ↗IKK classic€1awarded 21 May 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tacrolimus, ATC L04AD02 für die Zeit 01.09.2024 - 31.08.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Sept 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tacrolimus, ATC L04AD02, für die Zeit 01.09.2022 - 31.08.2024 ↗DAK-Gesundheitshared awardawarded 2 Sept 2022
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tacrolimus, ATC L04AD02, für die Zeit 01.09.2022 - 31.08.2024 ↗DAK-Gesundheitshared awardawarded 1 Sept 2022
- Germany-Stuttgart: Pharmaceutical products ↗AOK Baden-Württembergawarded 28 Oct 2017
- Bisoprolol + Amlodipin ↗IKK classicshared awardawarded 9 Dec 2016
- Vereinbarung nach § 130c SGB V für das Arzneimittel XtandiTM ↗AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen; Unternehmensbereich Corporate Governance; Geschäftsbereich Zentrale Vergabestelleawarded 11 Nov 2016
- Leuprorelin ↗Techniker Krankenkasseshared awardawarded 3 Mar 2016
- Formoterol (Darreichungsformen: Inhalationslösung; Dosieraerosol; Inhalationspulver) ↗Techniker Krankenkasseawarded 3 Mar 2016
- Fachlos 1; ATC-Code: L04AD02; Tacrolimus ↗spectrumK GmbHawarded 5 Feb 2016
- Medical equipment, pharmaceuticals & personal care — GWQ ServicePlus AG ↗GWQ ServicePlus AGawarded 22 Dec 2015
- Medical equipment, pharmaceuticals & personal care — Techniker Krankenkasse ↗Techniker Krankenkasseawarded 23 Nov 2015
- Medical equipment, pharmaceuticals & personal care — AOK Baden-Württemberg ↗AOK Baden-Württembergawarded 23 Oct 2015
- Medical equipment, pharmaceuticals & personal care — AOK Bayern – Die Gesundheitskasse ↗AOK Bayern – Die Gesundheitskasseawarded 12 Oct 2015
- Leuprorelin mit der Mindestindikation Prostatakarzinom als Retardmikrokapseln und Suspensionsmittel (z. B. Enantone; Trenantone; Sixantone) ↗AOK Baden-Württembergshared awardawarded 29 Jul 2015
- Leuprorelin; ATC-Code: L02AE02 ↗IKK classicshared awardawarded 22 Jul 2015
- Vertrag gem. § 130a Abs. 8 SGB V über den Wirkstoff Cilostazol ↗AOK Nordost – Die Gesundheitskasseshared awardawarded 30 Sept 2014
- Formoterol (Darreichungsformen: Dosieraerosol; Inhalationspulver) ↗Techniker Krankenkasseshared awardawarded 14 Nov 2013
- Medical equipment, pharmaceuticals & personal care — AOK Nordost - Die Gesundheitskasse ↗AOK Nordost - Die Gesundheitskasseawarded 2 May 2013
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- ASTELLAS PHARMA, S.A.258 awards
- Astellas Pharma172 awards
- ASTELLAS PHARMA S.P.A.96 awards
- Astellas Pharma s.r.o.32 awards
- Astellas Pharma A/S26 awards
- Astellas Pharma AB20 awards
- Astellas Pharma SAS4 awards
- Astellas Pharma (Alloga)3 awards
- Astellas Pharma (Depolabo)3 awards
- Astellas Pharma (Alloga Marseille)1 award
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.